No statistically significant differences were detected between STAT3/STAT5B-mutated vs. WT LGLL patients as regards sex, age, presence of organomegalies or associated neoplasias other than the clonal T/NK-cell expansion(s). This evidence concerns the gene STAT5B and neoplasm.